Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficacy and Safety Evaluating Fispemifene in the Treatment of Hypogonadal Men With Erectile Dysfunction Unresponsive to PDE5 Inhibitors
This study is currently recruiting participants.
Study NCT00415571   Information provided by QuatRx Pharmaceuticals Company
First Received: December 21, 2006   Last Updated: February 29, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hypogonadism
Erectile Dysfunction
More general conditions related to this trial
Endocrine System Diseases
Genital Diseases, Male
Gonadal Disorders
Mental Disorders
Sexual and Gender Disorders
Sexual Dysfunction, Physiological
Sexual Dysfunctions, Psychological
Sponsors listed in this trial
QuatRx Pharmaceuticals Company
Hormos Medical


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services